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Accumulation of lipid-laden “macrophage foam cell” in the arterial wall is the 
hallmark of atherosclerosis that leads to the highest number of cardiovascular 
disease-related deaths in United States. Membrane scavenger receptors such as 
SR-A, and CD36 play important role in controlling oxidized low-density 
lipoprotein binding and uptake, and, thereby, in macrophage foam cell formation. 
Recent studies also put emphasis on the role of mechanical factors, such as matrix 
stiffness, in the regulation of macrophage function and atherogenesis. However, 
the identity of a plasma membrane mechanosensor and the underlying 
mechanisms that may promote atherogenesis is yet to be identified. We have 
found that a calcium-permeable plasma membrane protein TRPV4, a 
mechanosensor, may play an essential role in regulating macrophage foam cell 
formation, a critical process in atherosclerosis. We have also found that TRPV4 is 
essential for oxLDL uptake, but not for its binding. Altogether, herein, we 
demonstrate that TRPV4 plays a critical role in macrophage-foam-cell formation 
by regulating oxLDL uptake in cells. 
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Chapter 1: Introduction 
Atherosclerosis is a chronic inflammatory cardiovascular disease (CVD) 
caused in part by lipid-laden foam cell accumulation in arterial wall (1). Impacts 
of this disease are quite extensive but ischemic heart disease and cerebrovascular 
diseases are two major forms of CVD, mostly affected by atherosclerosis. 
Together these two diseases are representing 84.5% of CVD related deaths and 
28.2% of all-cause mortality (68), hence, have become the most common cause 
of death in USA and in many advanced countries. Although this disease has huge 
negative impact in people life from advanced countries, the underlying 
mechanisms of this disease are poorly understood. 
Foam cell formation and its infiltration/accumulation to vascular intimal 
layer is a hallmark of atherosclerosis (1). During atherogenesis, phagocytosis of 
oxLDL by macrophage and formation of lipid-laden foam cells are considered to 
be the major pathogenic processes. Macrophage cell membrane scavenger 
receptors such as CD36, is known to play leading role in internalization of 
oxLDL and subsequent foam cell formation (3-5). Although scavenger receptors 
are well characterized, downstream signaling pathways of this receptor in 
oxLDL binding and uptake is not well understood. 
Increased reactive oxygen species (ROS) generation in atherosclerosis is 
well characterized phenomenon (1-7). ROS can oxidize phospholipids on the 
_______________________________________________________________________ 
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surface of LDL particles and transform them to oxLDL, which can be taken up 
by macrophage surface scavenger receptor such as CD36 (3-5). Uptake of 
oxLDL also increases ROS generation by feed-forward manner and plays a 
crucial role in the development and progression of atherosclerotic lesions (1-7). 
            Ca2+-dependent signaling is required for different macrophage functions 
such as, cell proliferation, differentiation, apoptosis, migration, adhesion (15-16). 
Ca2+ signaling dependent actin remodeling is important for phagocytosis in 
macrophage (16, 19) and association of calcium overload with the genesis of 
atherosclerotic lesion is well established (17, 18). Recent data has also indicated 
that different mechanical factor such as matrix stiffness, can regulate numerous 
physiological function, such as, vascular elasticity, macrophage activation and 
atherogenesis (22-29). However, the identity of a plasma membrane 
mechanosensor and the potential mechanisms by which mechanotransduction 
signals can be transduced/propagate in macrophages to promote atherogenesis is 
not understood.  
Emerging data from our group and others have provided evidence for the   
involvement of transient receptor potential cation channel subfamily V member 4 
(TRPV4) in  atherosclerotic macrophage functioning (12, 16-22). TRPV4 is a 
calcium-permiable, mechanotransductory membrane protein which is expressed 
ubiquitously in different cell types including macrophages (29-31). This channel 
is likned with different human diseases (45-47) and we hypothesize that TRPV4 
may module induction of arterial stiffness or macrophage foam cell formation by 
changing the Ca2+ intake and promoting inflammation in cells. 
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In this study we tested the hypothesis that TRPV4, a calcium 
permiable channel, may play a role in macrophage foam cell formation. To 
test this hypothesis, numerous ex vivo/in vitro experimentation were performed 
using murine bone marrow derived macrphages and murine resident 
macrophages. We found that functional TRPV4 channels in macrophages is 
regulating macrophage foam cell formation in the presence of oxLDL. Matrix 
stiffness-dependent potentiation of oxLDL uptake but not binding in  
macrophages is also dependent on TRPV4. Mechanistically, we showed that i) 
Plasma membrane localization of TRPV4 is facilitated by increasing matrix 
stiffness, and ii) decrease foam cell formation in TRPV4 KO macrophages is not 
due to lack of expression of CD36, a major receptor for oxLDL.  Altogether,  our 
results suggest that TRPV4 is critically involved in oxLDL-induced macrophage 
foam cell formation by regulating oxLDL uptake in cells. Thus, targeting TRPV4 









Chapter 2: Literature Review 
The major cause of mortality and morbidity in today’s world is 
atherosclerosis (1,2). Atherosclerosis is a chronic inflammatory disease and it is 
considered that atherosclerosis is initiated by endothelial dysfunction, which 
allows the retention of low-density lipoproteins (LDL) in the intima of inflamed 
arteries (1,3). An inflammatory response is triggered by the oxidative 
modifications of LDL (oxLDL) through enzymatic or non-enzymatic processes, 
which in turn activates endothelial cells, smooth muscle cells, and immune cells. 
This results in recruitment of monocytes into arterial intima (1,3–5). Monocyte-
derived macrophage uptake of oxLDL through scavenger receptors such as 
CD36 contributes to formation of the primary component of atherosclerotic 
lesions, the lipid-laden macrophage “foam cells” (3–5). The development and 
progression of atheroma plaques and consequent development of atherosclerosis-
related pathologies is caused by persistent accumulation of macrophage foam 
cells along with other cellular waste products, lipids, and calcium in the arterial 
intima (1–7). 
Overall oxidative stress can be enhanced by chronic inflammatory 
condition, which dramatically augments the production of reactive oxygen 
species (ROS). There is a well-recognized association between atherogenesis and 
heightened oxidative stress (1–7). Phospholipids on the surface of LDL particles 
can get oxidized by increment of ROS and generate atherogenic oxLDL particles 
which can be taken up specifically by macrophage scavenger receptors like 
CD36 and SR-A (3–5). It has been shown that uptake of oxLDL can also 
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enhance ROS generation following mitochondrial dysfunction which can 
promote macrophage death, a process likely to contribute to the development of 
necrotic cores and progression of atherosclerotic lesions (1–7). 
Macrophages are key player in atherogenesis by generating lipid-laden 
foam cells and by secreting inflammatory mediators (3–5). Previous studies also 
reported macrophage proliferation and accumulation in advanced lesions in 
atherosclerotic murine models (8). Deficiency of scavenger receptors in 
macrophages such as CD36 or SR-A blocked uptake of oxLDL and also reduced 
foam cell formation in mice (9–12). However, disparities have been observed 
regarding the role of scavenger receptors in foam cell formation. For example, 
ApoE null mice having a genetic deficiency in either CD36 or SR-A display 
increased atherosclerosis and increased numbers of macrophage foam cells 
(13,14). These findings suggest involvement of additional mechanisms in 
macrophage foam cell formation. 
Ca2+-dependent signaling is a critical component of numerous 
macrophage functions, including cell differentiation, proliferation, apoptosis, 
migration, adhesion, and mediating inflammatory responses (15,16). Calcium 
overload is associated with the genesis of atherosclerotic lesions (17,18) and 
phagocytosis and macrophage foam cell formation are also regulated by Ca2+ 
signaling (12,16,19,20). Macrophages have an intricate system of ion channels 
and membrane pumps that are responsible for regulating cellular Ca2+ 
homeostasis (21). Emerging data support a role for a mechanical factor, e.g., 
 6 
matrix stiffness, in regulation of numerous macrophage functions, vascular 
elasticity, and atherogenesis (22–29). 
TRPV4 calcium-permeable channel, a member of the transient receptor 
potential vanilloid (TRP) superfamily, is ubiquitously expressed in various cell 
types including macrophages (29–31). Previous reports by our group and others 
have shown that a range of biochemical and physical stimuli in vitro and in vivo 
stimulates TRPV4 (29–44). Various gain- and loss-of-function mutations in 
TRPV4 have been linked to human diseases including skeletal dysplasia and 
sensory and motor neuropathies (45–47). TRPV4 has been linked to multiple 
physiological functions including osmolarity sensing in kidneys, sheer-stress 
detection in blood vessels, and control of osteoclast differentiation in bone (32–
44). In mice, TRPV4 deficiency is associated with altered pressure/ vasodilatory 
responses, osmosensing, as well as lung and skin fibrosis (32–44). It has been 
reported that TRPV4 is a regulator of adipose oxidative metabolism, 
inflammation and energy homeostasis in obese mice models (48). TRPV4-null 
mice exhibit impaired endothelium-dependent relaxation induced by 
acetylcholine in vitro and in vivo (49). An athero-protective role of TRPV4 has 
been recently reported, whereby TRPV4 activation in endothelial cells induces 
eNOS activation and inhibits monocyte adhesion to endothelial cells (50). Thus, 
the role of TRPV4 in oxLDL-induced macrophage foam cell formation is critical 
to elucidate and important to determine the mechanism of its involvement in this 
process. It is hypothesized that TRPV4 calcium channels may play a role in 
macrophage foam cell formation because it is an important mechanosensor that 
 7 
responds to changes in tissue stiffness by permitting Ca2+ influx into the cell 
(29–44) and changes in substrate stiffness affects macrophage phenotype and 
function (22–29). In this research project, the role of TRPV4 in the uptake of 
















Chapter 3: Research Objectives  
Arterial stiffness is one of the most important pathophysiological 
symptoms of atherosclerosis. However, it is unknown whether matrix stiffness 
plays any role in macrophage foam cell formation. Here, we will test the 
hypothesis that TRPV4, a calcium-permiable channel, may play a role in 
macrophage foam cell formation.  
Research Aims 
 
1. Assess whether macrophage foam cell formation is dependent upon 
TRPV4. 
 
2. Determine whether deficiency of TRPV4 modulates matrix stiffness-
induced macrophage foam cell formation. 
 
3. Examine that TRPV4 is expressed and functional in mouse primary 
macrophages. 
 
4. Test whether matrix stiffness facilitates expression and/or plasma 
membrane localization of TRPV4. 
 
5. Determine mechanism of TRPV4-dependent foam cell formation 
Impacts 
 
TRPV4 is a mechanotransductor and Ca+2 permeable channel. It involves 
in macrophage foam cell formation, which is the most important hallmark of 
atherosclerosis. By dissecting the molecular mechanism of this complex process, 
we will advance our knowledge in understanding the underlying mechanism of 
atherogenesis.  Thus, results of this project may contribute to the future 
development of targeted therapies for atherosclerosis. 
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Chapter 4: Materials and methods 
Reagents and antibody 
Antibody to TRPV4 was purchased from Alomone Labs (Jerusalem, 
Israel) and anti-CD36 antibody was purchased from BD Pharmingen. Goat-anti 
rabbit Alexa Flour 488 was purchased form Life Technologies. Calcium 
ionophore A23187 (A23), GSK2193874 (GSK219), GSK1016790A (GSK101), 
DiI (1,1’-Dioctadecyl-3,3,3’,3’-tetramenthylindocarbocyanine per-chlorate) were 
purchased from Sigma Aldrich (St. Louis, MO, USA). GSK219 worked as 
TRPV4 antagonist by blocking the TRPV4 mediated Ca2+ influx into the cell and 
GSK101 was used as an agonist by giving rise to Ca2+ influx in cell. FLIPR 
Calcium 6 assay kit was purchased from Molecular Devices (Sunnyvale, CA, 
USA). Macrophage Colony Stimulating Factor (M-CSF) was purchased from R 
& D. To prepare copper-oxidized LDL (oxLDL) we incubate LDL (Stem cell 
Technologies) with CuSO4 (5µM) for 12 h at 37°C as described by Rahaman et 
al. (2006) (12). Martigen Life technologies (Brea, CA, USA) was the 
manufacturer of Easy Coat hydrogels of various stiffness (0.5, 8, 50 KPa). We 
obtained RPMI 1640, DMEM media and cell culture related agents from Gibco. 
Animal and Cell culture 
TRPV4 knockout (TRPV4 ko) mice, which were originally generated by 
Dr. Suzuki (Jichi Medical university, Tochigi, Japan), were obtained from Dr. 
Zhang (Medical College of Wisconsin, Milwaukee, WI). C57BL/6 congenic 
Wild type mice were purchased from Charles River Laboratories (Wilmington, 
Massachusetts, USA). Institutional Animal Care and Use committee guidelines 
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approved by the University of Maryland review committee were strictly followed 
to conduct all animal experiments. Animals were kept in a 12-hour dark/light 
cycle in a temperature and humidity controlled pathogen free environment and 
fed ad libitum. We followed previously described protocol (12, 20) to isolate 
murine resident macrophages (MRM) and bone marrow derived macrophages 
(BMDM). Peritoneal lavage was collected by PBS to isolate MRM while 
BMDM were harvested from mouse bone marrow cells by treating it with 
RPMI1640 medium with 7-8 days supplementation of M-CSF (50ng/mL) (12, 
20, 52, 53). All cells were incubated at 37°C and 5% CO2. 
Intercellular Calcium influx assay 
FLIPR Calcium 6 Assay kit (Molecular Device, Boston, USA) was used 
to measure changes in the BMDM cells. FlexStation system was used to detect 
signals (32, 34).  About 10,000 cells were seeded into each well of 96-well plate 
with 10% serum containing RPMI supplemented with 50ng/mL M-CSF. Cells 
were incubated for 24 hours and allow them to adhere with the base. FLIPR 
Calcium 6 dye in 1X HBSS, 20mM HEPES (pH 7.4) and 2.5 mM probenecid 
were added after that and incubated for 90 minutes. GSK101, TRPV4 agonist, 
was used to induce calcium influx into the cell (35, 37) and systolic influx of the 
calcium was recorded by measuring ΔF/F (Max-Min) as we have published 
before (32, 34). Relative fluorescence units (RFU) was used to show the data. 
Western Blot Analysis 
BMDMs were lysed in modified RIPA buffer which contains 50mM Tris-
HCl (pH 7.5), 150mM sodium chloride, 0.5% sodium deoxycholate, 1mM 
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EDTA, 1mM EGTA, 1% NP-40, 2.5mM Sodium pyrophosphate, 1mM β-
glycerophosphate, 1mM Na3VO4 and 1 µg/mL leupeptide (34). Protein 
concentration was measured by Bradford method and equal volume of protein 
were separated in 12% SDS-PAGE gel and then transferred to ployvinylidene 
difluoride membrane. Then the membrane was probed with CD36 antibody 
(1:1000), detected signal with ECL kit (Thermo Fischer Scientific) and an 
enhanced chemiluminescence system UVP Biospectrum (Upland, CA) was used 
to visualize and quantify. 
Immunofluorescence Analysis 
MRMs were seeded on variable stiffness hydrogel coverslip (1 KPa, 8 
KPa, 50KPa) and fixed with 3% paraformaldehyde. 1% Triton X-100 was used 
to permeabilize the cells and 3% BSA/PBS was used as blocker. Samples were 
incubated with anti-TRPV4 (1:100) IgG followed by goat-anti rabbit Alexa flour 
488 (1:300). Cells were mounted by using Prolonged Diamond Antifade DAPI 
containing reagent (Thermos Fischer Scientific). Cells were visualized at 63X by 
Zeiss Axio Observer microscope and ImageJ software from NIH was used to 
quantify immunofluorescence intensity.  
Oil Red O Foam Cell Assay 
Collagen coated (10µg/mL) glass coverslip or polyacrylamide hydrogels 
of varied stiffness (0.5 and 8KPa) coverslips were used for foam cell assay. 
MRM of both WT and TRPV4 ko were seeded on the coverslips in 10% serum 
containing RPMI 1640 and incubated for 48 hours. Floating cells were washed 
off and then added 50µg/mL of native LDL (nLDL) as control and oxidized LDL 
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(oxLDL) followed by 20 hours incubation. After incubation cells were fixed with 
10% formalin for 10 minutes and stained with Oil Red O (12, 20) and observed 
by Zeiss Axio Observer (40X) microscope.  
Binding and Uptake of oxLDL 
To perform binding assay, 10% SC-RPMI was used to seed MRM cells 
on glass coverslip and incubate with DiI-oxLDL (5µg/mL) for 60 minutes at 
4°C. Cells were washed after incubation and fixed with 10% formalin for 10 
minutes. Fluorescent intensity was visualized at 63X by Zeiss Axio Observer 
microscope and quantified by ImageJ Software (NIH). To examine uptake assay 
MRMs were treated similarly and seeded on glass coverslip but incubate with 
DiI-oxLDL for three different time points; 10, 30 and 60 minutes at 37°C (12, 
20, 52). Zeiss Axio observer was used to examine the cells (63X) and ImageJ 
software was used to quantify. 
Statistical analysis 
All data are expressed as mean ± SEM as indicate below. Statistical 
comparisons between control and experimental groups were performed with the 
two tailed Student’s t-test or one-way ANOVA using SigmaPlot (Systat 






Chapter 5: Results 
OxLDL-induced macrophage foam cell formation is dependent on 
TRPV4 
Macrophage foam cell formation is critically dependent on cytoskeletal 
remodeling (54, 55). Previous studies have suggested that cytoskeletal 
modification is crucial for force generation, which is essential for cell migration. 
This remodeling is dependent on Ca2+ influx which is highly dependent on 
TRPV4. We hypothesized that TRPV4 may play important role in macrophage 
oxLDL-internalization and subsequently to form foam cells.  To test our 
hypothesis, we compared the foam cell formation in WT and TRPV4 ko MRMs. 
We found a 7-fold increase in foam cell formation in oxLDL treated WT MRMs 
compared to nLDL treated cells. oxLDL-induced foam cell formation reduced 
significantly when TRPV4 is genetically deleted (Fig. 1A & B). This data 
suggests that presence of TRPV4 channels facilitate oxLDL-induced macrophage 




Figure 1. oxLDL-induced macrophage foam cell formation is TRPV4 dependent. A. 
WT and TRPV4 ko primary resident macrophages (MRM) were collected and cultured 


































(nLDL, 50µg/mL) or oxidized LDL (oxLDL, 50µg/mL). After fixing the cell, Oil Red O 
was used to stain and assess macrophage foam cell formation. Five different field per 
condition were examined and representative micrographs (original magnification 40X) 
are shown. B. Quantitation of results from 1A. Results are expressed as mean ± SEM. 
**p<0.01 for oxLDL treated TRPV4 ko vs WT cells; n = 500cells/condition. 
 
 
TRPV4 deficiency protect against matrix stiffness-induced 
macrophage foam cell formation induced by oxLDL 
 Matrix stiffness play a critical role in various macrophage functions such 
as, phagocytosis, motility, cell proliferation and adhesion (22-29). However, the 
identity of a plasma membrane protein, which also acts as a mechanosensor and 
transduces the mechanical signal to operate different macrophage function, is not 
yet characterized. Recent data have shown that TRPV4 channel plays important 
role in transforming growth factor-β1- induced and matrix stiffness-induced lung 
and dermal fibroblast differentiation, thus affecting the development of 
pulmonary or skin fibrosis in mice (32-34).  Here we observed that in higher 
stiffness (8KPa), amount of oxLDL induced foam cell formation in WT MRMs 
is 3-fold higher compare to low stiffness (0.5KPa). When we compared TRPV4 
ko MRMs with WT MRMs, both cell types seeded on higher stiffness (8KPa), 
we found 2-fold reduction of foam cell formation in TRPV4 ko. No significant 
difference was observed when we compared WT MRMs with TRPV4 ko MRMs 
plated on 0.5KPa stiffness gel (Fig 2A & B). This data suggests that matrix 
















Figure 2. oxLDL-induced macrophage foam cell formation in response to stiffness 
is regulated by TRPV4. A. WT and TRPV4 ko MRMs were grown on soft (0.5KPa) 
and stiff (8KPa) hydrogels for 24h and then incubated with oxLDL (50µg/mL) for 24h. 
Cells were stained with Oil Red O and examined five different field per condition. 
Representative images (original magnification 40X) are shown. B. Quantitation of 
results from 2A. Results are expressed as mean ± SEM. **p<0.01 for oxLDL treated 
TRPV4-/- vs WT cells; n = 50cells/condition, Student’s t-test.  
 
TRPV4 protein is expressed and functional in mouse primary 
macrophages 
GSK101, a selective TRPV4 agonist, (35) was used to detect the presence 
of TRPV4-mediated Ca2+ influx in macrophages. A rapid (within 20-50 seconds) 
rise in Ca2+ influx in WT BMDM was observed. This influx is concentration 
dependent, which means with increased dose of GSK101, the Ca2+ influx inside 
the macrophage would increase (Fig 3A). We found that half-maximal effective 
concentration (EC50) of GSK101 on BMDM is 12nM (Fig 3B). In case of 
TRPV4 ko BMDM we did not observe any Ca2+ influx in presence of GSK101, 
as expected (Fig 3C). This data provided evidence that TRPV4 is expressed in 










































Figure 3. TRPV4 calcium channel is functional in primary normal bone marrow-
derived macrophage (BMDM). A & C. BMDM cells from WT and TRPV4 ko mice 
were loaded with Calcium 6 dye and recorded calcium influx by FlexStation 3. Result 
showing effects of TRPV4 agonist GSK101 on Ca2+ influx of two different cell types. B. 
EC50 value of GSK101 for WT BMDM cells were measured. A23187 (A23) is a non-
specific calcium ionophore used as a positive control. 
 
Plasma membrane accumulation of TRPV4 is influenced by matrix 
stiffness 
 Plasma membrane localization of TRPV4 is influenced by various stimuli 
(56, 57). Previously, we found that with increasing matrix stiffness, TRPV4’s 
ability to modulate foam cell formation was increased (Fig 2). To understand the 
mechanism, we examined the plasma membrane localization of TRPV4 with 
increasing stiffness in WT MRMs. TRPV4 protein was not localized on plasma 
membrane when we seeded cells on 1kPa matrices. TRPV4 proteins were 
distributed throughout the cytoplasm of the cell in this case. However, in higher 
stiffness, such as 8KPa and 50KPa, we found significantly augmented TRPV4 



























































membrane localization could be facilitated by matrix stiffness. As we know from 
previous study that CD36 is a major receptor for oxLDL binding and uptake, we 
tested the expression level of CD36 in WT and TRPV4 ko MRMs by 
immunoblot analysis. We found no change in the level of CD36 protein 
expression (Fig 4 C). These data suggest that reduced macrophage foam cell 






Figure 4.  Increasing matrix stiffness enhance plasma membrane localization of 
TRPV4. A. WT MRM cells were seeded on various stiffness gels (1, 8 and 50 KPa) and 
incubated for 48h and then stained with anti TRPV4 IgG. Representative fluorescent 
images (original magnification was 40X; n = 10cells/condition) are shown TRPV4 
(green) WT MRMs. B. Plot profile using Image J software from TRPV4 stained cells 
showing plasma membrane localization of TRPV4 grown on stiff (8 and 50KPa) matrix 
compared to soft (1KPa). C. Representative immunoblot from three independent 
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oxLDL uptake, but not binding, is dependent on TRPV4 in 
macrophages 
 
In order to be engulfed by macrophages, lipid particles need to be first 
bound on the surface of macrophages and then subsequently following 
membrane remodeling lipid particles are taken inside the cell. We examined 
oxLDL binding and uptake by macrophages to assess the underlying mechanism 
of TRPV4-dependent macrophage-foam-cell formation. WT and TRPV4 ko 
MRMs were incubated with DiI-oxLDL for 1 hour at 4°C for binding assay. 
There was no significant difference in oxLDL binding in TRPV4 ko MRMs 
when we compare it with WT MRMs (Fig. 5A & B). For uptake assay, WT and 
TRPV4 ko MRMs were incubated with oxLDL for three different time points 
(10, 30, 60 minutes). TRPV4 ko MRMs showed significant reduction in DiI-
oxLDL uptake compared to WT MRMs with increasing time (Fig. 6A and B). 
This data suggests that TRPV4 plays a critical role in oxLDL uptake by 




Figure 5. DiI-oxLDL binding to macrophage is not dependent on TRPV4. A. MRMs 
were collected from WT and TRPV4 ko mice and cells were incubated with or without 
DiI-oxLDL (2.5µg/mL) for 1h at 4°C to assess oxLDL binding. Representative images 
of oxLDL bindng on macrophage membrane(n = 10 cells/ condition) are shown. DiI-
oxLDL binding indicated by red fluorescence. B. Plot profile by using ImageJ software 































Figure 6. TRPV4 is required for DiI-oxLDL uptake in macrophage. A. MRMs were 
collected from WT and TRPV4 ko mice and cells were incubated with or without DiI-
oxLDL (5µg/mL) for 10, 30 and 60 minutes at 37°C and uptake of oxLDL was assessed. 
Representative images from five different fields per condition were examined (orginal 
magnification, 40X). DiI-oxLDL uptake indicated by red fluorescence. B. Bar graphs 
show mean DiI fluorescence intensity (mean±SEM) analyzed using ImageJ software. *p 
< 0.05 and ***P < 0.001 for oxLDL uptake in TRPV4 ko vs WT cells at respective time 




















































Chapter 6: Discussion 
 
Results from this study showed that: i) oxLDL-induced macrophage foam 
cell formation is regulated by TRPV4 calcium-permeable channel; ii) 
pathophysiologically-relevant stiff matrix increase oxLDL-induced foam cell 
formation in a TRPV4-dependent manner; iii) TRPV4-dependent calcium influx 
regulates uptake of oxLDL into macrophage but not its binding to macrophage 
surface. We also demonstrate that reduced foam cell production in the absent of 
TRPV4 is not due to lack of expression of CD36, a major receptor for oxLDL. 
Furthermore, our data showed that plasma membrane localization of TRPV4 is 
sensitive to matrix stiffness. 
Previously, it has been shown that internalization and trafficking of 
oxLDL inside the macrophage is the main cause of lipid-laden foam cell 
formation. However, the identity and the nature of the molecular pathways 
regulating this process are still incompletely understood. Previous study from our 
laboratory and others have shown that uptake of oxLDL is a scavenger receptor-
mediated process (3-5, 9-13). It has been well known that Ca2+ signaling plays an 
important role in various cellular processes, including phagocytosis in various 
cell types, such as macrophages. To engulf materials, macrophage needs to 
generate phagocytic cap, which requires extensive actin remodeling inside the 
cell. It has been reported that this process requires involvement of extracellular 
Ca+2 influx (58, 59). We have also reported in our previous study that oxLDL 
can increase macrophage foam cell formation in a calcium influx dependent 
manner (15-20).  
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Stiffness dependent alteration of gene expression and respective 
molecular signaling is found to be involved in numerous cellular processes such 
as, fibrogenesis and oncogenesis (60, 66). During atherosclerosis, arterial 
epithelial wall becomes stiffer which elevates the risk of atherogenesis and is 
considered as a marker of atherosclerosis (23-25). Macrophage, an essential cell 
type in atherogenesis, is known to respond to changes to their surrounding 
mechanical environment (22-29). As such, it is important to identify the 
macrophage plasma membrane receptor by which mechanical signal is 
transduced into cell to promote atherogenesis. As TRPV4 channels can be 
sensitized by changes in matrix stiffness (22-29), we tested, whether macrophage 
foam cell formation is dependent on TRPV4. Previous reports on matrix stiffness 
dependent pro-atherogenic functions such as, phagocytosis, motility and 
proliferation of macrophages, indicated the role of matrix stiffness in pro-
atherogenic activity of macrophages in the context of atherosclerosis (22-29). 
TRPV4 activity is known to be regulated by both mechanical (e.g., matrix 
stiffness) and soluble (e.g., TGFb1) factors. This membrane protein is 
ubiquitously expressed in various cell types (29-44). TRPV4 deficiency has been 
linked to many pathophysiological processes in mice including vasodilatory 
responses, osmosensing, bone development, neurological functions and lung 
edema (29-44). Studies by our group recently have shown that TRPV4 knock out 
mice are protected from bleomycin induced lung and skin fibrosis (32, 33). 
Different human disease such as skeletal dysplasia and sensory and motor 
neuropathies have been linked with loss or gain of function of TRPV4 (45-47). 
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Osmolarity sensing in kidneys, sheer-stress detection in blood vessels, 
myofibroblast differentiation in lung and skin and control of osteoclast 
differentiation in bone are few examples where TRPV4’s role is shown to be 
important (29-44). In a recent study, involvement of TRPV4 has been recognized 
in matrix stiffness sensing and mechanosensing in macrophage function and 
atherosclerosis (22-29). Here, we found that in response to pathophysiological 
increase in matrix stiffness, plasma membrane localization of TRPV4 was 
upregulated in macrophages. We also found that increasing matrix stiffness 
influenced TRPV4 dependent exacerbation of oxLDL-induced foam cell 
formation. This could be a potential mechanism how TRPV4 activity is related to 
atherogenesis. Emerging data suggests role of Ca2+ signaling in foam cell 
formation (15-20) but which Ca2+ channels are involved or the mechanism by 
which Ca2+ signals promote atherogenesis is not understood. Interestingly, 
biochemical signals and mechanical signals both are involved in macrophage 
activation (22-29). These observations are relevant to the pathophysiology of 
atherosclerosis, wound healing and fibrosis in general. All these disease 
phenomena involve injuries that trigger atherogenic/fibrotic responses to increase 
tissue stiffness, which may subsequently influence overall activation of different 
cell types including macrophages and fibroblast in a positive feed-forward 
manner. 
Experimental and clinical data suggest that arterial stiffening and 
atherosclerotic burden has pathophysiological connection (22-29). Matrix 
remodeling, endothelial dysfunction and insulin resistance shares many 
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pathophysiological mechanisms with arterial stiffening and atherogenesis. In 
atherosclerosis, injuries trigger inflammatory responses to increase tissue 
stiffness, a very important pathophysiology of this disease. TRPV4 activation 
might be subsequently influenced by the tissue stiffness, which subsequently can 
increase macrophage foam cell formation in a positive feed-forward manner. The 
question of how different signaling events, such as matrix stiffness, 
hyperlipidemia, ROS and inflammation, might co-operate and/or integrate to 
affect atherogenesis remains to be elucidated. In our study, we found that oxLDL 
binding to the macrophage is not dependent on TRPV4. This could be due to the 
similar expression level of CD36, in macrophages. But in contrary, uptake of 
oxLDL in macrophage, which needs a robust remodeling of actomysin 
machinery, is significantly dependent on TRPV4. As previously shown, 
actomysin remodeling is critically dependent on TRPV4 dependent Ca2+ 
signaling during myofibroblast differentiation (32). Thus, in future studies it will 
be interesting to find out the mechanism by which actomysin modification-
dependent processes potentiates oxLDL-induced macrophage foam cell 
formation in a TRPV4 dependent manner. 
Being a ubiquitously expressed protein, TRPV4 has diverse role in 
different cell types (29-44). According to a recent report, TRPV4 agonist 
induced rise in cytosolic Ca2+ in endothelial cells inhibits vascular inflammation 
and atherosclerosis in mice model (50). There are evidences that TRPV4 is a 
modulator of adipose oxidative metabolism and inflammation (50) and 
deficiency of this protein in mice developed impaired endothelium-dependent 
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relaxation, induced by acetylcholine (49). All these different results suggest that 
cell type specific variation of roles of TRPV4 under different pathophysiological 
conditions. However, our results are consistent with a model that suggests 
TRPV4 mediated Ca2+ influx integrates matrix stiffness signals to promote 
macrophage foam cell formation, and hence, may contribute to development of 
atherosclerosis. Although, further studies are required to determine specific pro-
atherogenic and inflammatory functions of macrophage TRPV4, herein, we 
suggest a novel role of TRPV4 calcium-permeable channels in oxLDL-induced 
macrophage foam cell formation. Our data indicates that TRPV4-dependent 
foam cell formation in macrophage is sensitive to matrix stiffness. Altogether, 
our data suggests a novel role of this TRPV4 in atherogenesis. Thus, therapeutic 
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